Know Cancer

or
forgot password


N/A
18 Years
65 Years
Open (Enrolling)
Female
HPV-related Cytological Abnormalities on PAP Smear (LSIL)

Thank you

Trial Information


Inclusion Criteria:



- women with a new LSIL diagnosis an HPV positivity on PAP smear

Exclusion Criteria:

- women over 65

- immunocompromised patients (because of disease or drugs)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Outcome Measure:

1.proportion of HPV positives in both arms

Outcome Time Frame:

6months

Safety Issue:

No

Principal Investigator

veronique verhoeven, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universiteit Antwerpen

Authority:

Belgium: Institutional Review Board

Study ID:

2414VV

NCT ID:

NCT01097356

Start Date:

April 2010

Completion Date:

December 2010

Related Keywords:

  • HPV-related Cytological Abnormalities on PAP Smear (LSIL)
  • Congenital Abnormalities

Name

Location